Skip to main content

Find Clinical Trials

Home
Conditions
Intestinal Diseases

Clinical trial condition

Intestinal Diseases

Explore clinical trials studying Intestinal Diseases. Study availability and eligibility vary by location and protocol.

11,760 public trials 2,246 recruiting studies

Refine in advanced search Browse all conditions

Intestinal Diseases trial results

Recruiting

Autologous Stem Cell Transplantation for Crohn's Disease

NCT00692939

Conditions: Crohn Disease, Crohn's Disease, Digestive System Diseases, +4 more
Locations: UPMC Prebyterian- Adult Gastroenterology Pittsburgh, Pennsylvania, United States

Children's Hospital of Pittsburgh of UPMC-Bone Marrow Team Pittsburgh, Pennsylvania, United States

View Trial Details

Recruiting

Reduced Intensity Conditioning for Non-Malignant Disorders Undergoing UCBT, BMT or PBSCT

NCT01962415

Conditions: Adrenal Gland Diseases, Adrenal Insufficiency, Adrenoleukodystrophy, +125 more
Locations: UPMC Children's Hospital of Pittsburgh Pittsburgh, Pennsylvania, United States

View Trial Details

Recruiting

Post-resection/Ablation Chemotherapy in Patients With Metastatic Colorectal Cancer (FIRE-9 - PORT / AIO-KRK-0418)

NCT05008809

Conditions: Colonic Diseases, Colorectal Cancer, Colorectal Neoplasms, +9 more
Locations: Klinikum St. Marien Amberg Amberg, Germany

Helios Klinikum Bad Saarow Bad Saarow, Germany

Klinikum Bayreuth Bayreuth, Germany

Charité Universitätsmedizin Berlin Berlin, Germany

View all 79 locations

View Trial Details

Recruiting

Evaluation of the Natera Colorectal Cancer Screening Test in an Average Risk Population (FIND-CRC)

NCT07046585

Conditions: Colo-rectal Cancer, Colonic Diseases, Colonic Neoplasms, +10 more
Locations: Natera, Inc Austin, Texas, United States

View Trial Details

Recruiting

- IKF/AIO-QUINTIS - Evaluating Fruquintinib in Combination With Tislelizumab in Microsatellite Stable / Proficient Mismatch Repair (MSS/pMMR) Metastatic Colorectal Cancer Without Active Liver Metastases

NCT06856837

Conditions: Colonic Diseases, Colorectal Neoplasms, Digestive System Diseases, +9 more
Locations: Ordensklinikum Linz GmbH Linz, Austria

SCRI CCCIT Ges.m.b.H. Salzburg, Austria

Noe LGA Gesundheit Thermenregion GmbH Wiener Neustadt, Austria

Klinikum St. Marien Amberg Amberg, Germany

View all 23 locations

View Trial Details

Recruiting

APPI-Cost Trial for Perforated Appendicitis

NCT06705842

Conditions: Abdominal Abscess, Abscess, Appendicitis, +9 more
Locations: The University of Texas Health Science Center at Houston Houston, Texas, United States

View Trial Details

Recruiting

Evaluating a Nonessential Amino Acid Restriction (NEAAR) Medical Food With Total Neoadjuvant Therapy for Locally Advanced Rectal Cancer (LARC)

NCT06380101

Conditions: Colorectal Neoplasms, Digestive System Diseases, Digestive System Neoplasms, +9 more
Locations: University of South Florida Tampa, Florida, United States

View Trial Details

Recruiting

Safety of Trifluridine/Tipiracil in Patients With Dihydropyrimidine Dehydrogenase Deficiency Diagnosed With Metastatic Colorectal or Gastroesophageal Cancer

NCT06245356

Conditions: Colonic Diseases, Colorectal Neoplasms, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +18 more
Locations: CHU Amiens Amiens, France

Institut de Cancérologie de l'Ouest Angers, France

Institut du Cancer d'Avignon Avignon, France

CHU Jean Minjoz Besançon, France

View all 21 locations

View Trial Details

Recruiting

Robotic Inflammatory Bowel Disease Development, Learning and Efficacy Study

NCT06579443

Conditions: Colitis, Colitis, Ulcerative, Colonic Diseases, +7 more
Locations: University Hospitals Coventry & Warwickshire (UHCW) NHS Trust Coventry, West Midlands, United Kingdom

Newcastle Hospitals NHS Foundation Trust Newcastle upon Tyne, West Midlands, United Kingdom

Oxford University Hospitals NHS Foundation Trust Oxford, West Midlands, United Kingdom

London North West University Healthcare NHS Trust Harrow, United Kingdom

View Trial Details

Recruiting

A Clinical-biological Prospective Cohort of Patients With BRAFV600E-mutated Metastatic Colorectal Cancer

NCT05639413

Conditions: BRAF V600E Mutation Positive, Colonic Diseases, Colorectal Neoplasms, +10 more
Locations: Centre Hospitalier D'Avignon Avignon, France

Centre Hospitalier de Bayeux Bayeux, France

Chu Simone Veil Beauvais, France

Institut Bergonie Bordeaux, France

View all 45 locations

View Trial Details